These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Lambert-Eaton syndrome antibodies inhibit acetylcholine release and P/Q-type Ca2+ channels in electric ray nerve endings. Satoh Y; Hirashima N; Tokumaru H; Takahashi MP; Kang J; Viglione MP; Kim YI; Kirino Y J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):427-38. PubMed ID: 9508807 [TBL] [Abstract][Full Text] [Related]
23. [Immunopathogenesis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome]. Lisý L Bratisl Lek Listy; 1997 Apr; 98(4):217-20. PubMed ID: 9264830 [TBL] [Abstract][Full Text] [Related]
24. Calcium channel peptide can cause an autoimmune-mediated model of Lambert-Eaton myasthenic syndrome in rats. Komai K; Iwasa K; Takamori M J Neurol Sci; 1999 Jul; 166(2):126-30. PubMed ID: 10475106 [TBL] [Abstract][Full Text] [Related]
25. Synaptotagmin: a Lambert-Eaton myasthenic syndrome antigen that associates with presynaptic calcium channels. Martin-Moutot N; el Far O; Leveque C; David P; Marqueze B; Lang B; Newsom-Davis J; Hoshino T; Takahashi M; Seagar MJ J Physiol Paris; 1993; 87(1):37-41. PubMed ID: 8305896 [TBL] [Abstract][Full Text] [Related]
26. Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome. Takamori M; Takahashi M; Yasukawa Y; Iwasa K; Nemoto Y; Suenaga A; Nagataki S; Nakamura T J Neurol Sci; 1995 Nov; 133(1-2):95-101. PubMed ID: 8583238 [TBL] [Abstract][Full Text] [Related]
28. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma. Meriney SD; Hulsizer SC; Lennon VA; Grinnell AD Ann Neurol; 1996 Nov; 40(5):739-49. PubMed ID: 8957015 [TBL] [Abstract][Full Text] [Related]
29. Lambert-Eaton myasthenic syndrome as an autoimmune calcium channelopathy. Takamori M Biochem Biophys Res Commun; 2004 Oct; 322(4):1347-51. PubMed ID: 15336982 [TBL] [Abstract][Full Text] [Related]
30. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome]. Andreis I; Lovnićki TJ; Beara N; Taradi M Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205 [TBL] [Abstract][Full Text] [Related]
31. Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome. Lang B; Pinto A; Giovannini F; Newsom-Davis J; Vincent A Ann N Y Acad Sci; 2003 Sep; 998():187-95. PubMed ID: 14592874 [TBL] [Abstract][Full Text] [Related]
32. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse. Waterman SA; Lang B; Newsom-Davis J Ann Neurol; 1997 Aug; 42(2):147-56. PubMed ID: 9266723 [TBL] [Abstract][Full Text] [Related]
33. Myasthenia gravis with a paraneoplastic marker. Leavitt JA J Neuroophthalmol; 2000 Jun; 20(2):102-5. PubMed ID: 10870923 [TBL] [Abstract][Full Text] [Related]
35. Lambert-Eaton myasthenic syndrome. Seneviratne U; de Silva R Postgrad Med J; 1999 Sep; 75(887):516-20. PubMed ID: 10616683 [TBL] [Abstract][Full Text] [Related]
36. Conjoint occurrence of GABAB receptor antibodies in Lambert-Eaton myasthenic syndrome with antibodies to the voltage gated calcium channel. Dogan Onugoren M; Rauschka H; Bien CG J Neuroimmunol; 2014 Aug; 273(1-2):115-6. PubMed ID: 24929678 [TBL] [Abstract][Full Text] [Related]
37. Phoneutria nigriventer omega-Phonetoxin IIA: a new tool for anti-calcium channel autoantibody assays in Lambert-Eaton myasthenic syndrome. Martin-Moutot N; Haro Ld; Santos RG; Mori Y; Seagar M Neurobiol Dis; 2006 Apr; 22(1):57-63. PubMed ID: 16289869 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells. Viglione MP; O'Shaughnessy TJ; Kim YI J Physiol; 1995 Oct; 488 ( Pt 2)(Pt 2):303-17. PubMed ID: 8568672 [TBL] [Abstract][Full Text] [Related]